United States Isotretinoin Drugs Market Research Report to 2032
ID: MRFR/HC/11758-US | 100 Pages | Author: MRFR Research Team| December 2023
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
ID: MRFR/HC/11758-US | 100 Pages | Author: MRFR Research Team| December 2023
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
US Isotretinoin Drugs Market Highlighted Trends & Dynamics
North America dominates the isotretinoin drugs market, holding the largest share. This is attributed to well-established healthcare infrastructure, supportive government regulations, a growing incidence of skin problems, genetic disorders, and cancer, along with increased research and development investments in the region. The American Academy of Dermatology (AAD) has also taken a stance on oral isotretinoin, considering both the physical and psychological impacts of acne.Acne vulgaris affects around 85% of young adults aged 12 to 25 globally, according to the Global Burden of Disease (GBD) article. In North America, acne remains a prevalent skin issue, affecting 12% to 22% of adults in the US, according to global burden of disease surveys. The demand for acne treatment methods and pharmaceuticals has surged due to the expanding number of acne sufferers. In the US alone, over 50 million people are affected by acne annually.
An example of a significant development in the market is the launch of Absorica (isotretinoin) capsules by Teva Pharmaceutical Industries Ltd in April 2021. This marked the introduction of the first generic version for treating severe recalcitrant nodular acne in the US. The capsules, available in strengths ranging from 10 mg to 40 mg, were designed for the treatment of severe recalcitrant nodular acne in non-pregnant adults aged 12 and older with multiple inflammatory nodules measuring 5 mm or more in diameter.
Looking ahead, the North America isotretinoin drugs market is anticipated to achieve a Compound Annual Growth Rate (CAGR) of 5.06% from 2021 to 2027. This projection reflects the expected continued growth and demand for isotretinoin drugs in the region. The combination of factors such as the prevalence of skin issues, supportive regulatory environment, and ongoing research activities contributes to the positive outlook for the market in the coming years. The CAGR serves as an indicator of the potential expansion and stability of the isotretinoin drugs market in North America during the specified period.
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
